Internal Medicine, Nephrology · Oklahoma City, OK
NPI
1386992246
Since 2012
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3366 NW Expressway, Ste 550
Oklahoma City, OK, 73112
Phone (405) 942-5442
Groups this clinician bills Medicare through
Medicare paid, 2024
$201K
3,701 services
Medicare patients, 2024
460
Average age 72
Drug cost, 2024
$1.2M
2,857 prescriptions
Company payments, 2025
$1,181
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mamoon Rasheed was code 99458 (e&m - miscellaneous), 914 times for 110 patients. In total Mamoon Rasheed billed 3,701 services in 33 codes, and Medicare paid $201K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 914 | 110 | $29.10 | $27K |
| 99457 E&M - Miscellaneous | Office | 552 | 114 | $35.84 | $20K |
| 99454 E&M - Miscellaneous | Office | 409 | 101 | $32.92 | $13K |
| 99214 Office E&M - Established | Office | 408 | 214 | $56.77 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 375 | 136 | $56.82 | $21K |
| 90960 ESRD Related Services (not dialysis) | Office | 187 | 29 | $256.08 | $48K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 157 | 114 | $12.03 | $1,889 |
| 90935 Hemodialysis | Facility | 131 | 57 | $51.58 | $6,757 |
| 99233 Hospital E&M - Subsequent | Facility | 108 | 47 | $85.95 | $9,282 |
| 99453 E&M - Miscellaneous | Office | 95 | 95 | $13.81 | $1,312 |
| 99223 Hospital E&M - Initial | Facility | 71 | 69 | $127.04 | $9,020 |
| 99205 Office E&M - New | Office | 39 | 39 | $136.87 | $5,338 |
| 99231 Hospital E&M - Subsequent | Facility | 34 | 28 | $36.70 | $1,248 |
| 99215 Office E&M - Established | Office | 22 | 21 | $89.65 | $1,972 |
By year: 2022 $170K for 2,072 services; 2023 $146K for 1,895 services; 2024 $201K for 3,701 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mamoon Rasheed prescribed most often to Medicare patients was Torsemide, with 304 prescriptions and refills. In total Mamoon Rasheed wrote 2,857 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Torsemide Generic | 304 | 815 | 91 | $7,158 |
| Farxiga Dapagliflozin Propanediol | 172 | 236 | 29 | $116K |
| Lisinopril Generic | 150 | 400 | 50 | $1,545 |
| Carvedilol Generic | 139 | 363 | 52 | $2,123 |
| Terazosin Hcl Generic | 133 | 346 | 42 | $2,322 |
| Indapamide Generic | 112 | 291 | 33 | $1,393 |
| Jardiance Empagliflozin | 82 | 122 | 18 | $71K |
| Amlodipine Besylate Generic | 80 | 218 | 33 | $485 |
| Atorvastatin Calcium Generic | 77 | 228 | 28 | $2,138 |
| Losartan Potassium Generic | 71 | 210 | 28 | $1,185 |
| Telmisartan Generic | 70 | 172 | 21 | $2,082 |
| Hydralazine Hcl Generic | 61 | 128 | 25 | $762 |
| Allopurinol Generic | 60 | 160 | 21 | $1,418 |
| Rayaldee Calcifediol | 55 | 55 | Under 11 | $82K |
| Calcitriol Generic | 54 | 149 | 17 | $633 |
Brand drugs: 638 claims; generic drugs: 2,219 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mamoon Rasheed $1,181 ($1,181 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $239.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $239 |
| Travere Therapeutics, Inc. TVTX | 7 | $200 |
| Pharmacosmos Therapeutics Inc. | 2 | $170 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $149 |
| Vantive US Healthcare LLC | 1 | $149 |
| Calliditas Therapeutics US Inc. | 1 | $43.92 |
| Amgen Inc. AMGN | 2 | $38.95 |
| Mallinckrodt Hospital Products Inc. | 1 | $33.46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28.54 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $26.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.